Company profile for DiscGenics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. Improve the lives of those debilitated by degenerative diseases of the spine through innovative regenerative therapies. We are committed to achieving this mission by delivering high-quality products that mee...
DiscGenics is a privately held, clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. Improve the lives of those debilitated by degenerative diseases of the spine through innovative regenerative therapies. We are committed to achieving this mission by delivering high-quality products that meet or exceed customer requirements.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
5940 W Harold Gatty Drive Salt Lake City, UT 84116
Telephone
Telephone
(801) 410-0703
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/discgenics-announces-us-fda-approval-to-proceed-with-phase-iii-clinical-evaluation-of-allogeneic-injectable-disc-progenitor-cell-therapy-for-symptomatic-lumbar-degenerative-disc-disease-302198029.html

PR NEWSWIRE
16 Jul 2024

https://www.prnewswire.com/news-releases/discgenics-to-present-at-41st-annual-jp-morgan-healthcare-conference-301713390.html

PR NEWSWIRE
04 Jan 2023

https://www.prnewswire.com/news-releases/two-year-clinical-data-for-discgenicss-progenitor-cell-therapy-for-lumbar-disc-degeneration-to-be-presented-at-nass-2022-301646093.html

PRNEWSWIRE
11 Oct 2022

https://www.prnewswire.com/news-releases/discgenics-to-present-at-2022-cell--gene-meeting-on-the-mesa-301641614.html

PRNEWSWIRE
05 Oct 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty